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Temperature and heat exchange are at the 
base of biological processes throughout 
the realm of nature. In reptiles, a dif-
ference of less than one degree in the 
egg incubation temperature determines 
the sex of the newborn.[1] The swim-
ming speed of ciliated and flagellated 
unicellular species is also temperature-
dependent.[2] The human body is no 
exception. For instance, a temperature 
increase above the basal level could 
trigger physiological events such as modi-
fication of blood perfusion, alteration of 
cell dynamics, tumor matrix dismantling, 
blocking of DNA reparation mechanisms, 
increment of perfusion rates across cell 
membrane, and protein denaturation.[3–7] 
As a matter of fact, our body can delib-
erately elevate its temperature to sup-
port immune response against a plethora 
of conditions, which we experience as 
fever.[8] By the same token, activation of 
some of the abovementioned processes 
Deliberate and local increase of the temperature within solid tumors 
represents an effective therapeutic approach. Thermal therapies embrace this 
concept leveraging the capability of some species to convert the absorbed 
energy into heat. To that end, magnetic hyperthermia (MHT) uses magnetic 
nanoparticles (MNPs) that can effectively dissipate the energy absorbed 
under alternating magnetic fields. However, MNPs fail to provide real-time 
thermal feedback with the risk of unwanted overheating and impeding 
on-the-fly adjustment of the therapeutic parameters. Localization of MNPs 
within a tissue in an accurate, rapid, and cost-effective way represents 
another challenge for increasing the efficacy of MHT. In this work, MNPs 
are combined with state-of-the-art infrared luminescent nanothermometers 
(LNTh; Ag2S nanoparticles) in a nanocapsule that simultaneously overcomes 
these limitations. The novel optomagnetic nanocapsule acts as multimodal 
contrast agents for different imaging techniques (magnetic resonance, 
photoacoustic and near-infrared fluorescence imaging, optical and X-ray 
computed tomography). Most crucially, these nanocapsules provide accurate 
(0.2 °C resolution) and real-time subcutaneous thermal feedback during 
in vivo MHT, also enabling the attainment of thermal maps of the area 
of interest. These findings are a milestone on the road toward controlled 
magnetothermal therapies with minimal side effects.
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via localized heat delivery is the cornerstone of thermal 
therapies.[9–11]
Among these therapies, magnetic hyperthermia (MHT) 
achieves local temperature increase leveraging the ability of 
certain magnetic nanoparticles (MNPs) to generate heat when 
subjected to an alternating magnetic field.[12,13] The deep pene-
tration of magnetic fields within the human body, together with 
the possibility of targeting MNPs to specific tissues, have ena-
bled minimally invasive, local, and remotely activated heating 
showing high efficacy at the in vitro and in vivo levels.[14–23] 
Clinical trials have shown the efficacy of MHT to treat solid 
tumors, as well as to increase the usefulness of chemotherapy 
by enhancing drug permeability of cancer tissues.[24,25] Reaching 
high standards of efficacy and selectivity in MHT treatments 
requires full control over the remote heating process, which 
means precise localization of the MNPs and real-time thermal 
feedback into the treated tissue.[26,27] Thus, efficient in vivo tem-
perature reading methodologies allow assessing the efficacy 
and safety of the thermal treatment – a relevant limitation not 
yet addressed.
To tackle the first issue, in vivo localization of MNPs has been 
traditionally achieved via magnetic resonance imaging (MRI) 
and, more recently, magnetic particle imaging.[28–32] The high 
resolution and penetration depths offered by these techniques are 
curbed by long acquisition times and the need for sophisticated 
equipment. Therefore, alternative imaging modalities have been 
proposed. To that end, the ability of MNPs to provide single and 
multimodal in vivo images has been exploited by combining other 
techniques like optical coherence tomography (OCT), MRI, com-
puted tomography (CT), and photoacoustic (PA) imaging.[33–39] 
MNPs have also been combined with near-infrared (NIR)-emit-
ting nanoparticles (NPs) in a single hybrid structure, allowing 
multimodal imaging via NIR fluorescence and MRI.[40,41]
On the other hand, precise, real-time thermal feedback is 
needed for determining the delivered heat dose and for the 
dynamical setting of the treatment parameters.[42] Usually, tem-
perature monitoring during MHT is performed with infrared 
thermal cameras.[43] Albeit being simple and cost-effective, this 
approach provides information about the superficial tempera-
ture only (i.e., the skin), failing to give any reliable cue of the 
thermal state of deeper tissues. This is a pivotal aspect because, 
even during MHT of superficial tumors, the difference between 
intratumor and skin temperature could be greater than 
10  °C.[44,45] Luminescence thermometry could afford a reliable 
solution to this conundrum.
Luminescence thermometry is a contactless thermometric 
approach that allows garnering thermal information about tis-
sues in real-time. This is accomplished by harnessing tempera-
ture-dependent changes in the emission of luminescent species 
such as NPs, which effectively act as luminescent nanother-
mometers (LNThs).[46–49] LNThs have been employed to provide 
feedback during MHT both ex vivo and in vitro.[50,51] How-
ever, translation of these results to the in vivo level is no easy 
task. LNThs emitting in the second biological window (NIR-II, 
1000–1400  nm) are needed to ensure large optical penetra-
tion within tissues.[52,53] In addition, LNThs should have large 
thermal sensitivity (>1% °C–1), hence providing a thermal reso-
lution (ideally, sub-degree) smaller than the magnitude of the 
MHT-induced tissue heating.[53] In this vein, Ag2S NPs were 
recently shown to be prime candidates as in vivo LNThs, owing 
to their bright emission centered at approx. 1200 nm, excel-
lent biocompatibility, good physicochemical stability, and, most 
importantly, temperature-dependent optical properties.[54–63]
In this work, we propose a unique nanoplatform for in vivo 
heating, multimodal imaging, and real-time thermal moni-
toring in the form of a NIR-II-emitting optomagnetic nano-
capsule (NIR-MNC) obtained by phospholipid encapsulation of 
Ag2S-based NPs and MNPs (Figure 1A).
2. Results and Discussion
The Ag2S-based NPs consist of an Ag2S core passivated with 
layers of Ag2(S,Se),[64] to improve the optical properties and 
resistance to oxidation (henceforth, we refer to them simply 
as Ag2S NPs). MNPs are superparamagnetic Fe3O4 NPs. The 
detailed experimental procedures for the NPs synthesis and 
encapsulation are reported in Section S1, Supporting Informa-
tion. TEM observations revealed that, on average, within the 
nanocapsule multiple Ag2S NPs (mean diameter of 8.5  nm) 
are enclosed by Fe3O4 MNPs (mean diameter of 19 nm). This 
spatial arrangement of Fe3O4 and Ag2S NPs into the phos-
pholipidic capsule can be explained tentatively in terms of 
size-dependent interactions between the components of the 
asymmetric mixture, under the influence of the lipid mem-
brane on the MNPs. This assumption was corroborated by 
Monte Carlo (MC) simulations in the canonical ensemble 
(Section S2, Figure S1, Supporting Information), wherein an 
experimentally based modeling of both the size-dependent 
interparticle interactions and the modulation exerted by the 
lipid membrane on the MNPs was employed. The effective size 
of MNPs in organic media and NIR-MNCs in different aqueous 
media of relevance for biomedical applications was studied 
by dynamic light scattering (DLS; Figure  1B; and Section S3, 
Supporting Information). On one hand, a size of ≈ 20 nm for 
MNPs dispersed in octadecene reflects their individual disper-
sions (the size obtained from TEM observations is 19 ± 3 nm) 
Dr. G. Salas, Dr. A. Espinosa, Dr. F. J. Teran
Nanobiotecnología (IMDEA-Nanociencia)






Dr. L. Cussó, Dr. M. Desco
Departamento de Bioingeniería e Ingeniería Aeroespacial
Universidad Carlos III de Madrid
Madrid 28911, Spain
Dr. L. Cussó, Dr. M. Desco
Instituto de Investigación Sanitaria Gregorio Marañón
Madrid 28007, Spain
Dr. L. Cussó, Dr. M. Desco
Unidad de Imagen Avanzada
Centro Nacional de Investigaciones Cardiovasculares (CNIC)
Madrid 28029, Spain
Dr. L. Cussó, Dr. M. Desco
Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM)
Madrid 28029, Spain
Adv. Mater. 2021, 2100077
www.advmat.dewww.advancedsciencenews.com
2100077 (3 of 9) © 2021 The Authors. Advanced Materials published by Wiley-VCH GmbH
in organic media. On the other hand, typical values between 
150 and 200  nm were obtained for nanocapsules dispersed in 
double distilled water, phosphate-buffered saline (PBS 1×), and 
Dulbecco’s modified Eagle medium (DMEM). In blood plasma, 
the size increased up to ≈ 300 nm, owing to the formation of a 
protein corona that, by modifying the surface charge, induces 
agglomeration of the nanocapsules.[65]
The low polydispersity index (PDI) values in aqueous media 
(Table S1, Supporting Information) indicated a relatively narrow 
size distribution, which, along with a lack of aggregation (save 
in the case of plasma), further corroborated the colloidal sta-
bility of the NIR-MNCs. This stability resulted in comparable 
AC magnetization curves (Figure S2, Supporting Informa-
tion) and specific absorption rate (SAR) values in different 
aqueous media (see Figures S3 and S4, Supporting Informa-
tion). The efficient co-encapsulation of MNPs and Ag2S NPs 
was confirmed by the application of a magnetic field gradient 
(Figure  1C). Upon placing a magnet on one side of a cuvette 
containing a dispersion of NIR-MNCs, the colloid accumulated 
at the wall of the container under the drag of encapsulated 
Fe3O4 MNPs, leaving behind a clear solution. Fluorescence 
images (Figure 1C) showed no NIR emission from Ag2S NPs in 
the clear portion of the solution, evidencing the co-encapsula-
tion of the two moieties.
Notably, the absorption and emission spectra of NIR-MNCs 
(Figure  1D) are, in terms of bandwidth and central wave-
length, comparable to those previously reported for single Ag2S 
NPs[66] and to those of Ag2S-based NPs before encapsulation 
(Figure S5, Supporting Information), revealing that the NIR-II 
optical properties are retained by the Ag2S NPs in the nano-
capsule. Concerning the magnetic properties of NIR-MNCs, 
room-temperature magnetization cycles at 100  kHz and 
24 kA m−1 obtained for encapsulated and as-synthesized MNPs 
showed instead marked differences of the AC hysteresis loops 
(Figure  1E). Indeed, encapsulated MNPs featured larger coer-
cive fields, magnetization values, and magnetic area than the 
ones dispersed in organic solvent. This magnetization differ-
ence (up to twofold larger; Figure S4, Supporting Information) 
can be understood in terms of ordered spatial distributions 
of MNPs[67] that results in magnetising phenomena driven by 
nose-to-tail alignment of their magnetic moments. MC simu-
lations detailed in Section S2 of the Supporting Information 
predict a spatial order of MNPs into NIR-MNCs that, in com-
bination with recent predictions,[68] may explain the observed 
effective magnetization enhancement of encapsulated MNPs, 
and consequently their SAR values. Contrary to the case of a 
random MNP spatial distribution, the SAR values of NIR-
MNCs increased up to threefold with respect to the as synthe-
sized MNPs.[69,70]
Subsequently, the toxicity of the NIR-MNCs at the in vitro 
level was evaluated upon incubating MCF-7 cancer cells during 
4 and 24 h with nanocapsule dispersions at different extracel-
lular concentrations (0–50  µg mL−1; Figure 2A). No cytotox-
icity was observed at the tested conditions. Internalization 
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Figure 1. A) TEM image of a single NIR-MNC consisting of Ag2S NPs and Fe3O4 MNPs co-encapsulated by phospholipids. MNPs of larger size form 
a packed corona in the proximity of the nanocapsule’s surface, surrounding smaller Ag2S NPs. B) Comparison between the hydrodynamic size distri-
bution obtained via DLS on colloidal dispersions of MNPs in octadecene (ODE) and NIR-MNCs in distilled water, phosphate-buffered saline PBS 1×, 
DMEM, and blood plasma. C) Optical (top) and NIR-II (bottom) fluorescence images of a colloidal dispersion of NIR-MNCs in the absence (left) and 
presence (right) of a magnetic field gradient created by a neodymium magnet. NIR-MNCs are dragged towards the magnet so the solution becomes 
clear and luminescence is only generated in the vicinity of the magnet. D) Room-temperature extinction (gray line) and emission (orange line) spectra 
of a colloidal dispersion of NIR-MNCs. The emission spectrum was obtained under 800 nm optical excitation. E) Comparison between the AC magnetic 
hysteresis loops obtained at 100 kHz and 24 kA m−1 from individual (blue line) and encapsulated (orange line) MNPs dispersed in 1-octadecene and 
in double-distilled water, respectively.
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of NIR-MNCs by cells during incubation was corroborated 
by bright field microscopy (Section S6, Supporting Informa-
tion) and NIR-II fluorescence microscopy (Figure  2B). Cel-
lular uptake quantification revealed an average mass per cell 
of 0.76 ± 0.01 pgFe and 1.04 ± 0.01 pgAg (Figure S7, Supporting 
Information) after 24 h of incubation. The marked cell inter-
nalization of NIR-MNCs hinted at the amenability of these cap-
sules for thermal treatments of tumors, because the heat gener-
ated would be delivered efficiently to the cancer cells.
After ascertaining the lack of appreciable toxicity, the capa-
bility of NIR-MNCs to perform as multimodal imaging agents 
was assessed. In vitro tests were first conducted, which high-
lighted the possibility to use these capsules for MRI, NIR-II 
fluorescence imaging, OCT, CT, as well as PA imaging (Section 
S7 and Figure S8, Supporting Information). With this knowl-
edge at hand, we administered intravenously a NIR-MNCs 
suspension at a concentration of 2  mg mL−1 to three different 
mice (Figure 3A,B,C). Upon quantitative analysis of the images 
obtained via MRI, NIR-II imaging, and CT before and after injec-
tion, a similar biodistribution pattern was retrieved, showing 
preferential accumulation of the nanocapsules at the liver 
along with non-negligible collection at the lungs, kidneys, and 
stomach. For NIR-II imaging, the full biodistribution pattern 
was obtained from the analysis of the ex vivo images of the 
organs. Prominent accumulation of NIR-MNCs at the liver was 
also evidenced by an appreciable increase of the PA signal in 
correspondence with this organ (Figure  3D). To unequivocally 
correlate the enhancement of PA signal at the liver with the 
presence of NIR-MNCs, we recorded an in vivo PA excitation 
spectrum. The resemblance of this spectrum with the extinction 
spectrum of NIR-MNCs confirmed that the signal originated 
from the nanocapsules. 2D OCT images of ex vivo chicken 
breast tissue before and after injection of NIR-MNCs were also 
acquired, and they showed a marked increase of OCT contrast 
due to the presence of the nanocapsules (Figure  3E). Interest-
ingly, the diffusion of NIR-MNCs within the tissue allowed to 
visualize deep vessels otherwise not observable (contoured area).
Altogether, the images included in Figure  3 demonstrate the 
potential of the NIR-MNCs to act as multimodal contrast agents. 
This versatility allows selecting the imaging modality better suited 
for the specific application/tissue targeted as well as cross-checking 
the interpretation of images obtained with different techniques.
Last, the efficacy of NIR-MNCs as thermally self-monitored 
hyperthermia agents was assessed in a custom-designed com-
mercial equipment constituted of two coils connected to an 
AC generator that creates a homogeneous magnetic field at 
the mouse’s position (Figure 4A and Section S8, Supporting 
Information). To obtain a thermal read-out, the temperature-
dependent variations of the NIR-II emission band of Ag2S were 
harnessed (Figure  4B; and Sections S9 and Figure S10, Sup-
porting Information). As we previously reported, the integrated 
intensity of emission, I, was expected to decrease linearly with 
the temperature.[54] To thoroughly characterize the potential 
application of the Ag2S NPs in in vivo studies, we observed the 
thermal dependence of their luminescence spectrum under the 
presence of a biological tissue. More specifically, a 1-mm layer 
of murine skin was placed atop a microchannel containing a 
dispersion of the NIR-MNCs in water. The results are included 
in Figure  4C and they show that the luminescence could be 
effortlessly detected even at the highest tested temperatures. 
This through-tissue calibration of the luminescent thermom-
eter was preferred over a calibration in the absence of tissue 
since it better replicates the conditions of in vivo subcutaneous 
MHT monitoring (see Figure S11, Supporting Information and 












1 ) provided by the NIR-MNCs was approximately 
5.5% °C–1 in the 34–38 °C temperature range. This value is 
significantly larger than the thermal sensitivities achieved 
with other luminescent nanothermometers in this range.[71] To 
the best of our knowledge, there is only one published study 
reporting on the use of luminescent thermometers (Nd3+-doped 
fluoride NPs) supporting multimodal imaging.[72] However, in 
that study by Wang et  al., the relative thermal sensitivity was 
close to 2% °C–1 at room temperature and only MR and CT con-
trast capabilities were reported. The amalgamation of different 
moieties (MNPs and Ag2S NPs) with magnetic and optical 
properties in a single entity clearly allows achieving properties 
otherwise hardly attainable using these materials individually.
In addition to their thermal sensing ability, NIR-MNCs gen-
erate heat when subjected to alternating magnetic fields of 
Adv. Mater. 2021, 2100077
Figure 2. A) MCF-7 cell viability after incubation with NIR-MNCs at dif-
ferent extracellular concentrations. B) Optical (left) and NIR-II fluores-
cence (right) images of a single MCF-7 cancer cell after being incubated 
for 4 h with NIR-MNCs at a concentration of 50 µg mL−1. The fluorescence 
image was obtained under broadband excitation (500–900 nm) and emis-
sion (1000–1500 nm). Scale bars in (B) are 5 µm.
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different intensities and frequencies (Figure 4D,E). The heating 
efficiency increases with the amplitude of the magnetic field, 
and a 9 °C temperature increase was achieved after 5 min for 
the highest tested magnetic field intensity (16 kA m−1, 140 kHz). 
As expected, a linear dependence of the magnetic-field-induced 
temperature increment on the frequency of the magnetic field 
(12 kA m−1) was also observed (Figure 4E).
Encouraged by these observations, we tested the prowess 
of NIR-MNCs for thermally monitored in vivo MHT. To do so, 
we performed an intradermal injection of NIR-MNCs (100 µL, 
1.5 mg mL−1) in a CD1 mouse (Section S10, Supporting Informa-
tion). The anesthetized animal was placed inside our custom-
built system (Figure  4A). The system has an optical window 
to acquire the fluorescence image of the mouse during the 
application of the magnetic field. The excitation intensity (λex = 
800 nm) was set to 10 mW cm−2 to keep laser-induced heating at a 
minimum. NIR-II fluorescence images of the mouse before and 
5 min into the application of an AC magnetic field (20 kA m−1, 
140  kHz) showed a similar distribution of NIR-MNCs 
(Figure  4F). The partially quenched emission observed 5  min 
into the MHT treatment indicated local heating at the site of 
the intradermal injection. The temporal evolution of the NIR-II 
signal from NIR-MNCs (Figure 4G) showed a relative decrease 
of ≈ 15% during the application of the magnetic field. Upon 
switching off the applied field, the NIR-II signal recovered 
its original value. The drop in NIR-II intensity was translated 
to temperature units using the calibration curve reported in 
Figure 4C, resulting in a measured increase of the temperature 
Adv. Mater. 2021, 2100077
Figure 3. A) MRI, B) NIR-II, and C) CT images of mice before and 30 min after administration of a dispersion of NIR-MNCs (2 mg mL−1). 200 µL, 
100 µL, and 300 µL of NIR-MNCs dispersion were administered to each mouse, respectively. The biodistribution pattern obtained from each technique 
is also included. For MRI and CT, the patterns were obtained from in vivo images and the reported values are the product between the average contrast 
value for each organ obtained from image analysis and the weight of the organ. For NIR-II imaging (λex = 800 nm), the overall intensity from the dif-
ferent organs harvested after imaging (36 min in total; 30 min after injection + 6 min of imaging) was plotted. D) PA images of the liver (overlapped 
with ultrasound images) as obtained before and after intravenous (i.v.) injection of NIR-MNCs (100 µL, 1.5 mg mL−1). λex = 750 nm. The PA signal 
generated at the liver as a function of the excitation wavelength is also included (orange line), along with the absorption spectrum of NIR-MNCs (gray 
line). E) OCT images of chicken breast tissue before and after injection of NIR-MNCs (100 µL, 1.5 mg mL−1). The diffusion of NIR-MNCs into the tissue 
makes possible the visualization of internal structures such as the vessel in the contoured areas. The scale bar is 1 mm.
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Figure 4. A) Scheme of the setup used for in vivo MHT experiments. B) NIR-II emission spectra of a colloidal dispersion of NIR-MNCs (in water) 
under a 1 mm layer of murine skin at different temperatures. λex = 800 nm. C) Temperature dependence of the integrated emission intensity of the 
NIR-MNCs under ex vivo murine skin. The temperature was recorded with the aid of a thermocouple. Symbols are data obtained from the analysis 
of the emission spectra and the solid line is a guide for the eye. D) Temporal evolution of the temperature of a colloidal dispersion of NIR-MNCs in 
water for different AC magnetic field intensities with a frequency of 140 kHz. E) Temperature increment induced in a colloidal dispersion of NIR-MNCs 
subjected to a 12 kA m−1 AC magnetic field for different frequencies. Solution temperature was registered by an optical fibre thermal sensor. F) NIR-II 
fluorescence images of a CD1 mouse subjected to intradermal injection of NIR-MNCs before and 5 min after the application of a 20 kA m−1 magnetic 
field of 100 kHz frequency. G) Temporal evolution of the intradermal NIR-II emission intensity (orange) and the relative reduction in the NIR-II intensity 
(blue) during the application of a 20 kA m−1, 100 kHz AC magnetic field for 5 min. The relative intensity reduction was converted to a relative change 
of the intradermal temperature using the calibration curve reported in (C). For the sake of comparison, in (F), the thermal readout obtained with an 
infrared thermal camera is also reported (black line). H) Intradermal thermal image obtained in the presence of a 20 kA m−1, 140 kHz AC magnetic as 
obtained from the NIR-II fluorescence images obtained in the presence and absence of the magnetic field. Cutaneous thermal images acquired with 
an infrared thermal camera are also included. I) Temporal evolution of the intradermal temperature during the application of subsequent photothermal 
and hyperthermia processes as obtained from a thermal camera.
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close to 2.5 °C. The uncertainty of the thermal readout provided 
by the NIR-MNCs was determined to be 0.2 °C: This conserva-
tive estimate was obtained from the difference between the 
maximum and minimum temperature value during the first 
30 s of irradiation in the absence of applied AC magnetic field. 
The evolution of the local temperature during the MHT treat-
ment obtained via luminescence thermometry agreed well with 
the one measured with a thermal camera. Such agreement was 
expected because of the superficial nature of the intradermal 
injection, and it constitutes a solid proof of the reliability of 
the luminescence thermometric approach. Indeed, the reduced 
thickness of the dermis (<1  mm) allows efficient heat diffu-
sion so that a relatively small average temperature difference 
of 0.4 °C exists between the injection site and the external 
surface, although with larger, yet expected, differences during 
the heating and cooling transients (see Figure S12, Supporting 
Information, and discussion therein).
However, in the case of deeper tissues/organs, only NIR-
MNCs provide a temperature readout close to the real value. 
Ex vivo results included in Section S11, Figure S13, Supporting 
Information corroborate the superiority of approaches based on 
NIR-II emitting LNTh compared to the use of a thermal camera 
to gain knowledge about the thermal state below skin. From 
a technical viewpoint, real-time readout of the magnetically 
activated hyperthermia has the benefit of providing a useful 
feedback to adjust the AC magnetic field so as to set the most 
efficient thermal exposure for tumor treatment, minimizing 
the heating time.
Importantly, our experimental setup allowed obtaining the 
first-ever subcutaneous, in vivo 2D thermal images during 
MHT. The generic thermal image (ΔT(x,y)) was retrieved from 
the NIR-II images acquired in the absence (Ioff(x,y)) and in the 
presence (Ion(x,y)) of the magnetic field. By applying the cali-
bration obtained under ex vivo conditions to each pixel, the dif-
ference between the initial and final temperature at each point 
was retrieved and a spatial profile of the temperature could 
be built (Figure  4H). Comparison of the 2D thermal maps 
obtained with this approach and with a thermal camera high-
lights that the latter method shows a larger spatial spreading of 
the temperature. This is the result of heat conduction from the 
particles within the tissues. NIR-MNCs, instead, only provide 
thermal reading at the site where they are present.
Interestingly, thanks to the strong absorption from both Ag2S 
NPs and MNPs,[73,74] NIR-MNCs can also efficiently convert 
light-to-heat, making them suitable candidates for combined 
photothermal heating and magnetic hyperthermia.[75,76] Under 
continuous irradiation at a power density of 10 mW cm−2 (the 
one used for fluorescence imaging), a temperature increase of 
(0.10 ± 0.06) °C was observed. However, increasing the power 
density of the excitation light above that threshold, the intra-
dermal temperature was elevated by an amount dependent 
upon the power density itself (19 °C W cm−2)—Figure  4I). 
When the AC magnetic field was switched on, the magneti-
cally induced heating added to the one generated via laser 
irradiation. In our experimental conditions, combined photo-
thermal heating (laser power density of 260  mW cm−2) and 
magnetic hyperthermia (20 kA m−1, 140 kHz) led to an overall 
temperature increase close to 7 °C. The combination of photo-
thermal heating and MHT opens new horizons for advanced 
thermal therapies where, for example, the sub-tissue tempera-
ture can be orthogonally modulated by tuning of laser intensity 
and magnetic field amplitude/frequency.
3. Conclusions
We have synthesized optomagnetic nanocomposites by phos-
pholipid-mediated co-encapsulation of NIR-II-emitting fluo-
rescence nanothermometers (Ag2S nanoparticles) and heating 
mediators (Fe3O4 magnetic nanoparticles). The nanocapsules 
dispersed in water featured improved magnetic properties com-
pared to as-synthesized Fe3O4 magnetic nanoparticles dispersed 
in octadecene before encapsulation, likely due to collective 
magnetic effects. The capsules can act as sub-tissue multimodal 
contrast agents for magnetic resonance imaging, computed 
tomography, infrared fluorescence imaging, photoacoustic 
imaging, and optical computed tomography. Most importantly, 
the developed optomagnetic capsules enable real-time thermal 
feedback during in vivo magnetic hyperthermia with a thermal 
resolution of 0.2 °C, thanks to the thermal sensing ability of 
Ag2S nanoparticles. Furthermore, the use of these novel com-
posites allows building 2D thermal maps of the treated loca-
tion at the subcutaneous level: an actual “on-site” thermal scan 
synergic to the hyperthermia treatment. The herein reported 
results constitute a crucial step toward fully controlled magnetic 
hyperthermia treatments, where collateral damages deriving 
from overheating or heating of healthy tissues will be avoided.
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